{{Chembox
| ImageFile = 25N-NBOMe_structure_300px.png
|  ImageSize = 200px
| IUPACName = 2-(2,5-Dimethoxy-4-nitrophenyl)-''N''-(2-methoxybenzyl)ethanamine
| OtherNames = 2C-N-NBOMe, NBOMe-2C-N
| Section1 = {{Chembox Identifiers
|  CASNo = 1354632-03-3
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0G7SSW2N0S
|  PubChem = 118536028
|  ChemSpiderID = 52085577
|  SMILES = COC1=C(CCNCC2=C(OC)C=CC=C2)C=C(OC)C([N+]([O-])=O)=C1
|  StdInChI = 1S/C18H22N2O5/c1-23-16-7-5-4-6-14(16)12-19-9-8-13-10-18(25-3)15(20(21)22)11-17(13)24-2/h4-7,10-11,19H,8-9,12H2,1-3H3
|  StdInChIKey = TXCKTIBHURMASQ-UHFFFAOYSA-N
}}
| Section2 = {{Chembox Properties
|  C=18 | H=22 | N=2 | O=5 
|  Appearance = 
|  Density = 
|  MeltingPt = 
|  BoilingPt = 
|  Solubility = 
}}
| Section3 = {{Chembox Hazards
|  MainHazards = 
|  FlashPt = 
|  AutoignitionPt = 
}}
}}

'''25N-NBOMe''' ('''2C-N-NBOMe''', '''NBOMe-2C-N''') is a [[derivative (chemistry)|derivative]] of the [[hallucinogen]] [[2C-N]]. The pharmacological properties of 25N-NBOMe have not been described in the scientific literature, but it is believed to act in a similar manner to related compounds such as [[25I-NBOMe]] and [[25C-NBOMe]], which are potent [[agonist]]s at the [[5HT2A receptor|5HT<sub>2A</sub>]] [[Receptor (biochemistry)|receptor]].<ref>{{Cite journal | last1 = Hansen | first1 = M. | last2 = Phonekeo | first2 = K. | last3 = Paine | first3 = J. S. | last4 = Leth-Petersen | first4 = S. | last5 = Begtrup | first5 = M. | last6 = Bräuner-Osborne | first6 = H. | last7 = Kristensen | first7 = J. L. | doi = 10.1021/cn400216u | title = Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT<sub>2A/2C</sub> Agonists | journal = ACS Chemical Neuroscience | volume = 5 | issue = 3 | pages = 243–9  | year = 2014 | pmid = 24397362| pmc = 3963123
}}</ref><ref>[http://bitnest.ca/external.php?id=%2518%253A3%25172%251BE%2524K%255BG%2521%2524%257D%2504%2504V Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.]</ref> 25N-NBOMe has been sold as a street drug and has only been described in the literature in terms of identification by forensic analysis.<ref>{{cite journal|last=Casale|first=John F.|author2=Hays, Patrick A.|title=Characterization of Eleven 2,5-Dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) Derivatives and Differentiation from their  3- and 4-Methoxybenzyl Analogues - Part I|journal=Microgram Journal|year=2012|volume=9|issue=2|pages=84–109|url=http://www.justice.gov/dea/pr/microgram-journals/2012/mj9_84-109.pdf|accessdate=14 January 2014}}</ref><ref>{{cite journal | url=https://link.springer.com/article/10.1007%2Fs11419-013-0217-2 | title=Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products |vauthors=Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y | journal=Forensic Toxicology | year=2014 | volume=32 | issue=1 | pages=105–115 | doi=10.1007/s11419-013-0217-2}}</ref>

==Legality==
25N-NBOMe is illegal in Alabama,<ref>[https://legiscan.com/AL/text/SB333/id/988417/Alabama-2014-SB333-Enrolled.pdf Alabama Senate Bill SB 333: Controlled Substances]</ref> and Hungary.<ref>[http://www.daath.hu/incoming/designer_jogi_lista_20150903_BSZKI_Daath_kieg.pdf A Daath.hu kiegészítése a BSZKI "designer jogi listáján" nem szereplő, de az UP jegyzék 1.-4. szerkezeti leírásainak megfelelő, illetve az 5. felsorolásában szereplő néhány anyagról]</ref>

===Sweden===
[[Riksdag|The Riksdag]] added 25N-NBOMe to [[:sv:Narkotikastrafflagen|Narcotic Drugs Punishments Act]] under ''swedish schedule I'' (''"substances, plant materials and fungi which normally do not have medical use"'') as of January 16, 2015, published by [[Medical Products Agency (Sweden)|Medical Products Agency (MPA)]] in regulation ''LVFS 2014:11'' listed as '''25N-NBOMe''', and '''2-(2,5-dimetoxi-4-nitrofenyl)-N-(2-metoxibensyl)etanamin'''.<ref>https://lakemedelsverket.se/upload/lvfs/LVFS_2014_11.pdf</ref>

===United Kingdom===
{{N-benzylphenethylamine-Legality-United Kingdom}}

==See also==
* [[25B-NBOMe]]
* [[25C-NBOMe]]
* [[25I-NBOMe]]
* [[25TFM-NBOMe]]

==References==
{{Reflist}}

{{Hallucinogens}}
{{Serotonin receptor modulators}}
{{Phenethylamines}}

[[Category:25-NB (psychedelics)]]
[[Category:Nitro compounds]]
[[Category:Designer drugs]]


{{hallucinogen-stub}}